MESA, AZ / ACCESS Newswire / October 6, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) announced its plan to benchmark its upcoming AI diagnostic model against the HAM10000 public dermatology dataset to validate its image recognition architecture for detecting various skin lesion types.
The benchmarking process will help evaluate model precision, sensitivity, and specificity relative to peer-reviewed standards. The HAM10000 data will be used under its research license as part of MDCE’s ongoing proof-of-concept development.
“We are aligning our performance metrics with globally recognized academic standards,” said CEO Marshall Perkins III. “This proactive benchmarking approach underscores our focus on building credible, evidence-backed AI systems for healthcare.”
Company Website: www.medicalcaretechnologies.com
Safe Harbor Statement:
Forward-looking statements in this communication reflect current expectations and involve risks that may cause actual results to differ. Factors include data variability, integration challenges, and evolving regulatory guidance. The company assumes no obligation to update such statements.
Contact:
Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com
SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)
View the original press release on ACCESS Newswire
PLEASANTON, Calif., Feb. 6, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"),…
NEW YORK, Feb. 6, 2026 /PRNewswire/ -- Rokt, the leading ecommerce technology company using machine learning…
HONG KONG, Feb. 6, 2026 /PRNewswire/ -- CIMG Inc. ("CIMG" or the "Company") (Nasdaq: IMG),…
Validated by Claims Study dated, December,10, 2025, Airrosti providers showed $3.6K+ in savings per member…
DAVOS, Switzerland and MUMBAI, India, Feb. 6, 2026 /PRNewswire/ -- ACG Packaging Materials today announced…
Introducing cell therapy–grade cryopreservation and hypothermic storage solutions designed for consistency, quality, and performance across…